Lung Cancer Clinical Trials in Las Vegas, NV

Lung Cancer Clinical Trials in Las Vegas, NV

View the best 10 lung cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Lung Cancer clinical trial.

Trials in Las Vegas, Nevada

Here are the top 10 medical studies for lung cancer in Las Vegas, Nevada

Image of University of Alabama at Birmingham in Birmingham, United States.

Zimberelimab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will study the safety and effectiveness of two different immunotherapy treatments for people with non-small cell lung cancer.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of Alabama Oncology in Birmingham, United States.

Carboplatin +2 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing lurbinectedin in combination with atezolizumab compared to atezolizumab alone as maintenance therapy in people with small-cell lung cancer.
Image of Montefiore Medical Center - Moses Campus in Bronx, United States.

FSRS +1 More

Radiation Therapy

Recruiting1 award
This trial evaluates if a lower radiation dose over multiple days reduces side effects vs. one day of full radiation dose for cancer patients on immunotherapy.
Image of Providence Cancer Institute Franz Clinic in Portland, United States.

FF-10832 +1 More

Anti-metabolites

Recruiting3 awardsPhase 2
This trial is testing a new cancer drug, given in combination with another drug that is already used to treat cancer.
Image of Arizona Oncology Assoc, Pc-Hal in Phoenix, United States.

Pemetrexed +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a new way to treat lung cancer that may be more effective and have fewer side effects than the current standard of care.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

CAB-AXL-ADC +1 More

Antibody-drug conjugate

Recruiting1 awardPhase 2
This trial is testing a new cancer drug to see if it is safe and effective for patients with non-small cell lung cancer.
Image of Research Site in Bellflower, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether adding chemotherapy to osimertinib will help people with non-small cell lung cancer that has a specific DNA mutation and has gotten worse despite osimertinib.
Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Sacituzumab Govitecan-hziy (SG) +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare overall survival of two treatments for lung cancer patients who have progressed after other treatments.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.